Dimension Capital Management LLC Atara Biotherapeutics, Inc. Transaction History

Dimension Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Dec 01, 2023	SELL	$1.41 - $2.31 $19,740 - $32,340	-14,000 Reduced 50.0%	14,000 $20,000
Q3 2023 Nov 14, 2023	SELL	$1.41 - $2.31 $19,740 - $32,340	-14,000 Reduced 50.0%	14,000 $20,000
Q2 2023 Dec 01, 2023	BUY	$1.5 - $3.04 $21,000 - $42,560	14,000 Added 100.0%	28,000 $45,000
Q2 2023 Aug 14, 2023	BUY	$1.5 - $3.04 $21,000 - $42,560	14,000 Added 100.0%	28,000 $45,000
Q4 2022 Feb 14, 2023	BUY	$2.85 - $5.18 $39,900 - $72,520	14,000 New	14,000 $45,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Dimension Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dimension Capital Management LLC with notifications on news.